Literature DB >> 7753969

Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.

H E Shannon1, F P Bymaster, J C Hendrix, S J Quimby, C H Mitch.   

Abstract

The purpose of the present studies was to compare a novel series of alkoxy-oxazolyl-tetrahydropyridines (A-OXTPs) as muscarinic receptor antagonists. The affinity of these compounds for muscarinic receptors was determined by inhibition of [3H]pirenzepine to M1 receptors in hippocampus, [3H]QNB to M2 receptors in brainstem, and [3H]oxotremorine-M to high affinity muscarinic agonist binding sites in cortex. All of the compounds had higher affinity for [3H]pirenzepine than for [3H]QNB or [3H]oxotremorine-M labeled receptors, consistent with an interpretation that they are relatively selective M1 receptor antagonists, although none were as selective as pirenzepine. In addition, dose-response curves were determined for antagonism of oxotremorine-induced salivation (mediated by M3 receptors) and tremor (mediated by non-M1 receptors) in mice. In general, the A-OXTPs were equipotent and equieffective in antagonizing both salivation and tremor, although there were modest differences for some compounds. Dose-response curves also were determined on behavior maintained under a spatial-alternation schedule of food presentation in rats as a measure of effects on working memory. The A-OXTPs produced dose-related decreases in percent correct responding at doses three- to ten-fold lower than those which decreased rates of responding. However, only one compound, MB-OXTP, produced effects on percent correct responding consistent with a selective effect on memory as opposed to non-memory variables. The present results provide evidence that these alkoxy-oxazolyl-tetrahydropyridines are a novel series of modestly M1-selective muscarinic receptor antagonists, and that one member of the series, MB-OXTP, appears to be more selective in its effects on memory than previously studies muscarinic antagonists.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753969     DOI: 10.1007/BF02245189

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Muscarinic M3 receptors mediate secretion from sweat glands in the rat.

Authors:  A Schiavone; A Brambilla
Journal:  Pharmacol Res       Date:  1991-04       Impact factor: 7.658

2.  Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems.

Authors:  Y S Dai; I S Ambudkar; V J Horn; C K Yeh; E E Kousvelari; S J Wall; M Li; R P Yasuda; B B Wolfe; B J Baum
Journal:  Am J Physiol       Date:  1991-12

3.  Assessment of working memory in rats using spatial alternation behavior with variable retention intervals: effects of fixed-ratio size and scopolamine.

Authors:  H E Shannon; K G Bemis; J C Hart
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Trihexyphenidyl--further evidence for muscarinic receptor subclassification.

Authors:  X Y Tien; L J Wallace
Journal:  Biochem Pharmacol       Date:  1985-02-15       Impact factor: 5.858

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.

Authors:  N J Buckley; T I Bonner; C M Buckley; M R Brann
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

7.  Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool.

Authors:  I Q Whishaw; J A Tomie
Journal:  Behav Neurosci       Date:  1987-10       Impact factor: 1.912

8.  Evidence against a specific effect of cholinergic drugs on spatial memory in primates.

Authors:  N M Rupniak; N A Samson; S J Tye; M J Field; S D Iversen
Journal:  Behav Brain Res       Date:  1991-04-18       Impact factor: 3.332

9.  Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

Authors:  C Bolden; B Cusack; E Richelson
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

10.  Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.

Authors:  F P Bymaster; I Heath; J C Hendrix; H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.